Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance

L. Mráziková, S. Hojná, P. Vaculová, Š. Strnad, V. Vrkoslav, H. Pelantová, M. Kuzma, B. Železná, J. Kuneš, L. Maletínská

. 2023 ; 15 (2) : . [pub] 20230105

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc23004647

Prolactin-releasing peptide (PrRP) is an anorexigenic neuropeptide that has potential for the treatment of obesity and its complications. Recently, we designed a palmitoylated PrRP31 analog (palm11-PrRP31) that is more stable than the natural peptide and able to act centrally after peripheral administration. This analog acted as an anti-obesity and glucose-lowering agent, attenuating lipogenesis in rats and mice with high-fat (HF) diet-induced obesity. In Wistar Kyoto (WKY) rats fed a HF diet for 52 weeks, we explored glucose intolerance, but also prediabetes, liver steatosis and insulin resistance-related changes, as well as neuroinflammation in the brain. A potential beneficial effect of 6 weeks of treatment with palm11-PrRP31 and liraglutide as comparator was investigated. Liver lipid profiles, as well as urinary and plasma metabolomic profiles, were measured by lipidomics and metabolomics, respectively. Old obese WKY rats showed robust glucose intolerance that was attenuated by palm11-PrRP31, but not by liraglutide treatment. On the contrary, liraglutide had a beneficial effect on insulin resistance parameters. Despite obesity and prediabetes, WKY rats did not develop steatosis owing to HF diet feeding, even though liver lipogenesis was enhanced. Plasma triglycerides and cholesterol were not increased by HFD feeding, which points to unincreased lipid transport from the liver. The liver lipid profile was significantly altered by a HF diet that remained unaffected by palm11-PrRP31 or liraglutide treatment. The HF-diet-fed WKY rats revealed astrogliosis in the brain cortex and hippocampus, which was attenuated by treatment. In conclusion, this study suggested multiple beneficial anti-obesity-related effects of palm11-PrRP31 and liraglutide in both the periphery and brain.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004647
003      
CZ-PrNML
005      
20231004100000.0
007      
ta
008      
230418s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/nu15020280 $2 doi
035    __
$a (PubMed)36678151
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Mráziková, Lucia $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, 160 00 Prague, Czech Republic $7 xx0307846
245    10
$a Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance / $c L. Mráziková, S. Hojná, P. Vaculová, Š. Strnad, V. Vrkoslav, H. Pelantová, M. Kuzma, B. Železná, J. Kuneš, L. Maletínská
520    9_
$a Prolactin-releasing peptide (PrRP) is an anorexigenic neuropeptide that has potential for the treatment of obesity and its complications. Recently, we designed a palmitoylated PrRP31 analog (palm11-PrRP31) that is more stable than the natural peptide and able to act centrally after peripheral administration. This analog acted as an anti-obesity and glucose-lowering agent, attenuating lipogenesis in rats and mice with high-fat (HF) diet-induced obesity. In Wistar Kyoto (WKY) rats fed a HF diet for 52 weeks, we explored glucose intolerance, but also prediabetes, liver steatosis and insulin resistance-related changes, as well as neuroinflammation in the brain. A potential beneficial effect of 6 weeks of treatment with palm11-PrRP31 and liraglutide as comparator was investigated. Liver lipid profiles, as well as urinary and plasma metabolomic profiles, were measured by lipidomics and metabolomics, respectively. Old obese WKY rats showed robust glucose intolerance that was attenuated by palm11-PrRP31, but not by liraglutide treatment. On the contrary, liraglutide had a beneficial effect on insulin resistance parameters. Despite obesity and prediabetes, WKY rats did not develop steatosis owing to HF diet feeding, even though liver lipogenesis was enhanced. Plasma triglycerides and cholesterol were not increased by HFD feeding, which points to unincreased lipid transport from the liver. The liver lipid profile was significantly altered by a HF diet that remained unaffected by palm11-PrRP31 or liraglutide treatment. The HF-diet-fed WKY rats revealed astrogliosis in the brain cortex and hippocampus, which was attenuated by treatment. In conclusion, this study suggested multiple beneficial anti-obesity-related effects of palm11-PrRP31 and liraglutide in both the periphery and brain.
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a myši $7 D051379
650    _2
$a zvířata $7 D000818
650    _2
$a potkani inbrední WKY $7 D011921
650    12
$a porucha glukózové tolerance $x farmakoterapie $7 D018149
650    12
$a inzulinová rezistence $7 D007333
650    _2
$a hypoglykemika $x farmakologie $x terapeutické užití $7 D007004
650    _2
$a liraglutid $x farmakologie $x terapeutické užití $7 D000069450
650    _2
$a hormon uvolňující prolaktin $x farmakologie $7 D056690
650    12
$a prediabetes $x farmakoterapie $7 D011236
650    _2
$a obezita $x farmakoterapie $7 D009765
650    _2
$a lipidy $7 D008055
650    _2
$a dieta s vysokým obsahem tuků $x škodlivé účinky $7 D059305
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hojná, Silvie $u Institute of Physiology, Czech Academy of Sciences, 142 20 Prague, Czech Republic
700    1_
$a Vaculová, Petra $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, 160 00 Prague, Czech Republic
700    1_
$a Strnad, Štěpán $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, 160 00 Prague, Czech Republic $1 https://orcid.org/0000000207692420
700    1_
$a Vrkoslav, Vladimír $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, 160 00 Prague, Czech Republic $1 https://orcid.org/0000000251268360
700    1_
$a Pelantová, Helena $u Institute of Microbiology, Czech Academy of Sciences, 142 20 Prague, Czech Republic $1 https://orcid.org/0000000225237413
700    1_
$a Kuzma, Marek $u Institute of Microbiology, Czech Academy of Sciences, 142 20 Prague, Czech Republic
700    1_
$a Železná, Blanka $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, 160 00 Prague, Czech Republic
700    1_
$a Kuneš, Jaroslav $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, 160 00 Prague, Czech Republic $u Institute of Physiology, Czech Academy of Sciences, 142 20 Prague, Czech Republic
700    1_
$a Maletínská, Lenka $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, 160 00 Prague, Czech Republic
773    0_
$w MED00189563 $t Nutrients $x 2072-6643 $g Roč. 15, č. 2 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36678151 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20231004095956 $b ABA008
999    __
$a ok $b bmc $g 1925000 $s 1190856
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 15 $c 2 $e 20230105 $i 2072-6643 $m Nutrients $n Nutrients $x MED00189563
LZP    __
$a Pubmed-20230418

Find record

Citation metrics

Archiving options